lazabemide has been researched along with Brain Ischemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akaike, N; Himori, N; Suzuki, T; Tanaka, Y; Ueno, K | 1 |
| Haapalinna, A; Jolkkonen, J; Kauppinen, R; Nyman, L; Sivenius, J | 1 |
2 other study(ies) available for lazabemide and Brain Ischemia
| Article | Year |
|---|---|
MAO inhibitors, clorgyline and lazabemide, prevent hydroxyl radical generation caused by brain ischemia/reperfusion in mice.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain Ischemia; Clorgyline; Dopamine; Hydroxyl Radical; Male; Mice; Mice, Inbred Strains; Monoamine Oxidase Inhibitors; Picolinic Acids; Reperfusion | 1995 |
MAO-B inhibition by a single dose of l-deprenyl or lazabemide does not prevent neuronal damage following focal cerebral ischaemia in rats.
Topics: Animals; Brain; Brain Ischemia; Cerebral Infarction; Male; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Neurons; Picolinic Acids; Rats; Rats, Wistar; Selegiline | 2000 |